Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 112-119 , 2009

Demographic, laboratory and clinical characteristics of HIV-positive tuberculosis cases in Canada

  • G.J. Wang

      Affiliations

    • Anti-Tuberculosis Institute, Henan Provincial Centre for Disease Control and Prevention, 105 Nongye East Road, Zhengdong New District, Zhengzhou, Henan 450016 People's Republic of China
    • ,
  • M. Phypers

      Affiliations

    • Tuberculosis Prevention and Control, Public Health Agency of Canada, 100 Eglantine Driveway, Tunney's Pasture, AL0603B, Ottawa, Ontario, Canada K1A 0K9
    • Corresponding Author InformationCorresponding author at: 160 Elgin Street, Ottawa, Ontario, Canada. Tel.: +1 613 697 5772.
    • ,
  • E. Ellis

      Affiliations

    • Tuberculosis Prevention and Control, Public Health Agency of Canada, 100 Eglantine Driveway, Tunney's Pasture, AL0603B, Ottawa, Ontario, Canada K1A 0K9

Received 19 April 2009 ,Accepted 9 July 2009.

References 

  1. World Health Organization. Global tuberculosis control 2009: epidemiology, strategy, financing: WHO report 2009.
  2. Public Health Agency of Canada, Tuberculosis in Canada 2007. Ottawa (Canada): Minister of Public Works and Government Services Canada; 2009.
  3. Public Health Agency of Canada. HIV/AIDS Epi Updates, November 2007. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control. Public Health Agency of Canada; 2007.
  4. Harris T, Panaro L, Phypers M, Choudhri Y, Archibald C. HIV testing among Canadian tuberculosis cases from 1997 to 1998. CCIDMM 17[3]; 2006. p. 165–8.
  5. Canadian Tuberculosis Committee . Recommendations for the screening and prevention of tuberculosis in patients with HIV and the screening for HIV in tuberculosis patients and their contacts. Can Commun Dis Rep. 2002;28(ACS-7):1–6
  6. Long R, Ellis E, editors. Canadian tuberculosis standards. 6th ed. Ottawa ON: Her Majesty the Queen in Right of Canada, represented by the Minister of Health; 2007.
  7. World Health Organization , International Union Against Tuberculosis and Lung Disease , Royal Netherlands Tuberculosis Association . Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001;5(3):213–215
  8. Centres for Disease Control and Prevention . Reported HIV status of tuberculosis patients—United States, 1993–2005. MMWR. 2007;56(42):1103–1106
  9. Atomiya AN, Uip DE, Leite OH. Evaluation of disease patterns, treatment and prognosis of tuberculosis in AIDS patient. Braz J Infect Dis. 2002;6(1):29–39
  10. Lawson L, Yassin MA, Thacher TD, Olatunji OO, Lawson JO, Akingbogun TI, et al. Clinical presentation of adults with pulmonary tuberculosis with and without HIV infection in Nigeria. Scand J Infect Dis. 2008;40(1):30–35
  11. Talbot EA, Kenyon TA, Moeti TL, Hsin G, Dooley L, El-Halabi S, et al. HIV risk factors among patients with tuberculosis—Botswana, 1999. Int J STD AIDS. 2002;13(5):311–317
  12. Kassu A, Mengistu G, Ayele B, Diro E, Mekonnen F, Ketema D, et al. Co-infection and clinical manifestations of tuberculosis in human immunodeficiency virus-infected and -uninfected adults at a teaching hospital, northwest Ethiopia. J Microbiol Immunol Infect. 2007;40(2):116–122
  13. Report on the global AIDS epidemic 2008. Joint United Nations Programme on HIV/AIDS. Report No.: UNAIDS/08.25E/JC1510E; 2008.
  14. Yoshiyama T, Supawitkul S, Kunyanone N, Riengthong D, Yanai H, Abe C, et al. Prevalence of drug-resistant tuberculosis in HIV endemic area in northern Thailand. Int J Tuberc Lung Dis. 2001;5(1):32–39
  15. Iseman MD. Extrapulmonary tuberculosis in adults. A clinician's guide to tuberculosis. Philadelphia, PA: Lippincott, Williams & Wilkins; 2000;p. 145–97
  16. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis. 1997;24(4):661–668
  17. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120(4):316–353
  18. Kourbatova EV, Leonard MKJ, Romero J, Kraft C, del Rio C, Blumberg HM. Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US. Eur J Epidem. 2006;21(9):715–721
  19. Kipp AM, Stout JE, Hamilton CD, Van Rie A. Extrapulmonary tuberculosis, human immunodeficient virus, and foreign birth in North Carolina, 1993–2006. BMC Public Health. 2008;8:107
  20. Ciglenecki I, Glynn JR, Mwinga A, Ngwira B, Zumla A, Fine PEM, et al. Population differences in death rates in HIV-positive patients with tuberculosis. Int J Tuberc Lung Dis. 2007;11(10):1121–1128
  21. Myers JN. Miliary, central nervous system, and genitourinary tuberculosis. Dis Mon. 2007;53(1):22–31
  22. DeRiemer K, Soares EC, Dias SM, Cavalcante SC. HIV testing among tuberculosis patients in the era of antiretroviral therapy: a population-based study in Brazil. Int J Tuberc Lung Dis. 2000;4(June (6)):519–527

☆ All authors attest to having contributed substantially to conception and design and acquisition of data and drafting the article and revising it critically for important intellectual content and giving final approval of the version to be published.

PII: S1876-0341(09)00054-9

doi: 10.1016/j.jiph.2009.07.003

Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 112-119 , 2009

Article Tools